Cargando…

Oestrogen receptor status and survival in women with BRCA2-associated breast cancer

BACKGROUND: To evaluate the predictors of mortality, including ER status, in women with a BRCA2 mutation and breast cancer. METHODS: Eligible participants were identified from within two longitudinal cohorts. These patients were selected because they were diagnosed with breast cancer between 1975 an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Metcalfe, Kelly, Lynch, Henry T., Foulkes, William D., Tung, Nadine, Olopade, Olufunmilayo I., Eisen, Andrea, Lerner-Ellis, Jordan, Snyder, Carrie, Kim, Shana J., Sun, Ping, Narod, Steven A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462020/ https://www.ncbi.nlm.nih.gov/pubmed/30723304 http://dx.doi.org/10.1038/s41416-019-0376-y

Ejemplares similares

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
por: Metcalfe, Kelly, et al.
Publicado: (2014)

Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
por: Metcalfe, Kelly A, et al.
Publicado: (2005)

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Metcalfe, K, et al.
Publicado: (2011)

Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a BRCA1 or BRCA2 Mutation
por: Guyonnet, Emma, et al.
Publicado: (2023)

Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Kotsopoulos, Joanne, et al.
Publicado: (2005)

Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation
por: Mansfield, Carol A., et al.
Publicado: (2020)

Breast cancer survival in Nordic BRCA2 mutation carriers—unconventional association with oestrogen receptor status
por: Olafsdottir, Elinborg J., et al.
Publicado: (2020)

International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation
por: Metcalfe, Kelly, et al.
Publicado: (2019)

Building the What Comes Next Cohort for BRCA1 and BRCA2 testing: a descriptive analysis
por: Dossa, Fahima, et al.
Publicado: (2021)

Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment
por: Liede, Alexander, et al.
Publicado: (2017)

Breast cancer prevention in women with a BRCA1 or BRCA2 mutation
por: Metcalfe, Kelly A, et al.
Publicado: (2007)

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Kotsopoulos, Joanne, et al.
Publicado: (2012)

Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol
por: Dossa, Fahima, et al.
Publicado: (2018)

Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers
por: Friedman, Eitan, et al.
Publicado: (2006)

Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers
por: Jonasson, Jon G, et al.
Publicado: (2016)

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
por: Iqbal, J, et al.
Publicado: (2012)

Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis
por: Metcalfe, Kelly A., et al.
Publicado: (2020)

The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study
por: Iqbal, Javaid, et al.
Publicado: (2016)

Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation
por: Metcalfe, Kelly A, et al.
Publicado: (2007)

Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations
por: Bramley, M, et al.
Publicado: (2006)

Survival from breast cancer in women with a BRCA2 mutation by treatment
por: Evans, D. Gareth, et al.
Publicado: (2021)

Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers
por: Neuhausen, Susan L, et al.
Publicado: (2009)

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study
por: Phelan, C M, et al.
Publicado: (2014)

Rapid progression of prostate cancer in men with a BRCA2 mutation
por: Narod, S A, et al.
Publicado: (2008)

Prospective study of high-risk, BRCA1/2-mutation negative women: the ‘negative study’
por: Kotsopoulos, Joanne, et al.
Publicado: (2014)

Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis
por: Baretta, Zora, et al.
Publicado: (2016)

Looking for BRCA1 and BRCA2 mutations in Asian women with breast cancer
por: Narod, Steven A.
Publicado: (2023)

c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells
por: Chen, Yinghua, et al.
Publicado: (2011)

Response to ‘Comments on 'The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study''
por: Narod, Steven A
Publicado: (2016)

Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutation
por: Ertmański, S, et al.
Publicado: (2012)

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment
por: Robson, Mark E, et al.
Publicado: (2004)

Theory‐based behavior change intervention to increase uptake of risk‐reducing salpingo‐oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trial
por: Metcalfe, Kelly A., et al.
Publicado: (2023)

Vitamin D and Calcium Supplement Use and High-Risk Breast Cancer: A Case–Control Study among BRCA1 and BRCA2 Mutation Carriers
por: Guyonnet, Emma, et al.
Publicado: (2023)

Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers
por: Eisen, Andrea, et al.
Publicado: (2008)

Oestrogens and oestrogen receptors in prostate cancer
por: Kowalska, Karolina, et al.
Publicado: (2016)

Of Oestrogens and Sperm: A Review of the Roles of Oestrogens and Oestrogen Receptors in Male Reproduction
por: Dostalova, Pavla, et al.
Publicado: (2017)

Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation
por: Metcalfe, K A, et al.
Publicado: (2009)

Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

Genetic testing women with newly diagnosed breast cancer: What criteria are the most predictive of a positive test?
por: Metcalfe, Kelly A., et al.
Publicado: (2022)

Oestrogen-receptor status and sites of metastasis in breast cancer.
por: Campbell, F. C., et al.
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_a5u0plpcc7oo0ldntbnk0j2en8